Have Any Questions?

+91 9041415569

Have Any Questions?

+91 7009150400

Floxoptho DF Eye Drops

Composition: Difluprednate 0.05% w/v + Moxifloxacin 0.5% w/v

Formulation: Eye Drops

Category: Antibiotic + Corticosteroid

Packaging: 10ML

Enquire Now

Floxoptho DF Eye Drops

Description

Therapy/Class: Antibiotic + Corticosteroid

Mechanism of Action:

Difluprednate: A difluorinated synthetic corticosteroid derivative (butyrate ester) demonstrating robust anti-inflammatory efficacy. It induces phospholipase A2 inhibitory proteins (lipocortins), thereby strictly modulating the arachidonic acid cascade and downregulating the release of pro-inflammatory cytokines, leukotrienes, and prostaglandins without significant mineralocorticoid activity.

Moxifloxacin: An 8-methoxy advanced generation fluoroquinolone that optimally inhibits both Topoisomerase II and Topoisomerase IV. The methoxy group at the C-8 position minimizes the selection of resistant mutants and broadens coverage against atypical, Gram-positive, and Gram-negative organisms in ocular infections.

Indications

Treatment of bacterial conjunctivitis caused by susceptible organisms

Superficial ocular bacterial infections as advised by the treating ophthalmologist

Note: This is an indicative Indication, please follow the doctors advise. Do not self medicate.

Dosage & Administration

Instill 1 drop into the inferior conjunctival cul-de-sac of the affected eye(s) as prescribed by the physician. Dosing frequency should be adjusted according to clinical response and severity.

Note: This is an indicative dosage, please follow the doctors advise. Do not self medicate.

References

1. Korenfeld MS, et al. Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and pain. J Cataract Refract Surg. 2009;35(1):26-34.

2. Foster CS, et al. Efficacy and safety of difluprednate in endogenous anterior uveitis. Am J Ophthalmol. 2010;150(5):612-618.

1. Stroman DW, et al. In vitro and in vivo efficacy of moxifloxacin and gatifloxacin against ocular pathogens. Surv Ophthalmol. 2005;50 Suppl 1:S16-24.

Warning: This information is only for the use of registered medical practitioners only.

Frequently Asked Questions

What type of formulation is Floxoptho DF start?

It is an ophthalmic eye drops formulation.

How should Floxoptho DF start be used?

It should be used exactly as prescribed by a doctor, usually by instilling 1–2 drops into the affected eye without touching the dropper tip.

Which eye conditions can Floxoptho DF start to help manage?

It helps manage bacterial eye infections with inflammation, such as conjunctivitis and post-operative ocular inflammation.

How quickly does Floxoptho DF start working?

Improvement is usually seen within 1–3 days, depending on severity.

What should patients do if they miss a dose?

Use it as soon as remembered, but skip it if it’s almost time for the next dose, do not double the dose.

Does Floxoptho DF support long-term ocular care?

No, it is intended for short-term use only and should not be used long-term due to the steroid component.

Should Floxoptho DF be used without medical advice?

No, it should only be used under medical supervision.

Can contact lenses be worn while using Floxoptho DF?

No, contact lenses should be avoided during use unless advised by a doctor, as they may worsen irritation or infection.

What should patients know before using Floxoptho DF?

Use only under medical advice, maintain hygiene, avoid touching the dropper tip, and inform your doctor about any allergies or eye conditions.

How is Floxoptho DF supplied?

It is supplied as a sterile ophthalmic eye drop bottle in a sealed pack, as prescribed by the manufacturer.

Certified Manufacturing Standards

Disclaimer: This content is compiled from various references. We do not endorse any of it. Readers are advised not to self-medicate and to follow a doctor’s prescription and guidance.